Business Wire

KIRIN Develops Technology to Enhance Heat and Drought Tolerance in Hop Seedlings Contributing to a Sustainable Supply of Beer Ingredients Amid Climate Change

Share

Kirin Holdings Company, Limited (Kirin) (TOKYO: 2503) has developed a seedling cultivation technology that enhances heat and drought tolerance in hops through acquired tolerance, helping to address the growing challenges of reduced yield and quality caused by extreme heat and drought. This method enables hops to gain resilience without compromising flavor quality, and is expected to contribute to a more sustainable and stable supply of beer ingredients. This technology was presented at the Scientific-Technical Commission of the International Hop Growers' Convention in June 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250924957521/en/

Field trial in Iwate Prefecture. Variety: Saaz. Left: untreated control plants; Right: heat-treated plants.

Background of the Research

  • Global warming is known to act as heat stress on plants, inhibiting their growth*1. Hops, which prefer cool climates, suffer from poor growth under high temperatures and dry conditions, leading to declining yields and quality worldwide. This raises concerns about rising raw material costs and impacts on product quality, necessitating the development of technologies enabling stable cultivation and procurement even under climate change.

*1 In plants, temperatures higher than their optimal growth range cause heat stress. This can lead to delayed growth and symptoms such as leaf whitening.

Research Overview

  • Leveraging Kirin’s long-standing expertise in plant cultivation technologies*2 , we have developed a seedling production technique to induce heat tolerance and drought tolerance in hop seedlings. This is achieved by growing the seedlings in a liquid medium and applying a six-week heat treatment at 25°C during the mass propagation process. Unlike traditional breeding or genetic modification, this technique allows hops to acquire resilience without altering their original aroma or flavor profile. This research was evaluated using the Czech variety “Saaz” and the German variety “Hersbrucker.”

*2 Kirin Succeeds in Developing the World’s First Technology to Promote Axillary Bud Formation in Hops—A Breakthrough in Mass Propagation of Hop Plants (Website in Japanese)

Research Findings

Laboratory evaluation of high-temperature and dry environments

  • In laboratory tests simulating high-temperature and drought-conditions*3, heat-treated hop plants exhibited significantly higher plant height and chlorophyll*4 content compared to untreated control plants, demonstrating improved growth and enhanced tolerance.

*3 Drought condition testing was conducted using the “Saaz” variety only.
*4 Chlorophyll is a natural green pigment essential for photosynthesis. As leaves wither, they turn white or yellow due to reduced chlorophyll levels.

Cultivation evaluation at the test field

  • In cultivation evaluations conducted in Esashi City, Iwate Prefecture, heat-treated hop plants showed significantly higher plant height and above-ground weight compared to untreated control plants, and tended to produce higher cone yields.

Future Outlook

  • Moving forward, we will advance the refinement of mass seedling production technology, elucidate physiological changes induced by heat treatment, and verify applicability across multiple fields and varieties, while exploring implementation overseas. Our company aims to contribute to the realization of a sustainable beer ingredient supply.

The Kirin Group will continue to tackle complex and interrelated environmental issues (biological resources, water resources, containers and packaging, and climate change) in an integrated manner, and to work together with all those involved in the value chain to link our desire to enjoy and pass on the bounty of the Earth’s abundance to future generations. We will actively promote various initiatives that have a ‘positive impact’ on nature and people.

Reference: Kirin’s Environmental Initiatives

Kirin Group's Environmental Vision 2050 | The Environment | KIRIN - Kirin Holdings Company, Limited
Kirin Group Environmental Report | Sustainability Information | KIRIN - Kirin Holdings Company, Limited

Attachment: "Research Findings"

Background and Objective

  • Hops are a dioecious vine plant belonging to the Cannabaceae family. The female flowers, known as strobili, contain diverse secondary metabolites that impart bitterness, aroma, and antimicrobial properties to beer, making them an essential ingredient in brewing. Hops are plants that prefer cool climates and are primarily cultivated in regions between 35° and 55° north and south latitude, such as Europe, North America, and Australia. In response to recent declines in hop yield and quality due to rising temperatures and drought, accelerating Research and Development on climate change adaptation—including breeding improvements and cultivation techniques—to achieve sustainable raw material procurement has become an urgent priority.

Research Methodology

  • Methods for conferring stress tolerance to plants include breeding, genetic modification, the use of biostimulants, and environmental condition control. This study selected environmental condition control, as it is expected to have minimal impact on flavor. Specifically, we developed a technique to confer acquired heat and drought tolerance by growing hop seedlings in liquid medium and applying a six-week heat treatment at 25°C during the propagation process. This study evaluated the Czech variety “Saaz” and the German variety “Hersbrucker”.

Research Findings

1. Stress Tolerance Evaluation in Laboratory Conditions

  • In tests conducted under both high-temperature and drought-conditions *5, heat-treated hop plants showed significantly higher plant height and chlorophyll content compared to untreated control plants, confirming improved growth and enhanced tolerance.

*5 Drought condition testing was conducted using the “Saaz” variety only.

2. Field Evaluation in Japan

  • In April 2023, heat-treated plants and untreated control plants were planted in Esashi City and Tono City, both located in Iwate Prefecture, and evaluated over a two-year period.
  • In Esashi City, where the average temperature from May to September is approximately 2°C higher than in Tono City, heat-treated plants showed a significant tendency toward larger aboveground weight and higher boll yield compared to untreated control plants. No significant difference was observed in Tono City, where temperatures are lower than in Esashi City.

About Kirin Holdings

Kirin Holdings Company, Limited is an international company that operates in the Food & Beverages domain (Food & Beverages businesses), Pharmaceuticals domain (Pharmaceuticals businesses), and Health Science domain (Health Science business), both in Japan and across the globe.

Kirin Holdings can trace its roots to Japan Brewery which was established in 1885. Japan Brewery became Kirin Brewery in 1907. Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers. In 2007, Kirin Holdings was established as a pure holding company and is currently focusing on boosting its Health Science domain.

Under the Kirin Group Vision 2027 (KV 2027), a long-term management plan launched in 2019, the Kirin Group aims to become “A global leader in CSV*, creating value across our world of Food & Beverages to Pharmaceuticals.” Going forward, the Kirin Group will continue to leverage its strengths to create both social and economic value through its businesses, with the aim of achieving sustainable growth in corporate value.

*: Creating Shared Value. Combined added value for consumers as well as for society at large.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250924957521/en/

Contacts

Press Contact
Corporate Communication Department
Kirin Holdings Company, Limited
Nakano Central Park South, 4-10-2 Nakano, Nakano-ku, Tokyo
+81-3-6837-7028
Media Inquiries | KIRIN - Kirin Holdings Company, Limited -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ffaq.kirin.co.j
p%2Fform%2Fkh_10_en.html&esheet=54329484&newsitemid=20250924957521&lan=en-US&anc
hor=Media+Inquiries+%7C+KIRIN+-+Kirin+Holdings+Company%2C+Limited&index=4&md5=e7
0dc75e6cff94d774c8ebf778c2ed72
https://www.kirinholdings.com/en/ -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kirinholdi
ngs.com%2Fen%2F&esheet=54329484&newsitemid=20250924957521&lan=en-US&anchor=https
%3A%2F%2Fwww.kirinholdings.com%2Fen%2F&index=5&md5=6d6b12e38f8b7be88f6cd17d2c9a9
57e
kirin-cc@kirin.co.jp

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press Release

Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of annual net turnover. SWIFT SRG 2025 is another seismic update, representing the

TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press Release

TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver

RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge ® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press Release

Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support commercial manufacturing of Omisirge® for this additional indication at its state-of-the-art cGMP cell therapy manufacturing facility in Hopkinton, MA. “We are excited to expand our collaboration with RoslinCT to add US manufacturing as Omisirge® moves into its next phase with the recent FDA approval for patients suffering from severe apl

Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press Release

Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It proves a supplier has undergone an exhaustive audit of its governance, security controls, and operational processes. For Dutch financial institutions, this qualificatio

Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press Release

Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye